Health care company Baxter International, Inc. (BAX) reported Thursday a net loss attributable to shareholders for the first quarter of $15 million or $0.03 per share, compared to net income of $126 million or $0.25 per share in the prior-year quarter.
Excluding items, adjusted income from continuing operations for the quarter was $0.37 per share, compared to $0.62 per share last year.
Worldwide net sales for the quarter grew 3 percent to $2.70 billion from $2.63 billion in the same quarter last year. It declined 1 percent on an organic basis.
Continuing operations exclude Baxter's Kidney Care business, which was divested in January 2025, and is reported as discontinued operations.
Looking ahead to fiscal 2026, the company continues to project adjusted earnings from continuing operations in a range of $1.85 to $2.05 per share on sales growth from continuing operations of flat to 1 percent on a reported basis, with flat organic sales growth from continuing operations.
In Thursday's pre-market trading, BAX is trading on the NYSE at $17.66, up $0.75 or 4.47 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.